
Kenneth Lindegaard Madsen
Chief Development Officer & Co-Founder
Kenneth is Associate Professor at Molecular Neurophamacology and Genetics Group, Department of Neuroscience at University of Copenhagen.
Kenneth has a strong expertise on protein-protein interactions and cellular trafficking processes related to synaptic transmission. Kenneth has more than 20 years of experience with the biology of the synaptic scaffold protein PICK1 and has solved the molecular structure. Moreover, he has developed a novel quantitative method for assessing binding of scaffold proteins to membrane proteins in their native membrane environment. Together these efforts have enabled the rational design and patenting of bivalent, high-affinity inhibitors to potently target PICK1 in pain and addiction.
Kenneth has a strong national and international network with researchers covering organic chemistry, synthetic biology, structural biology, cell biology, synaptic transmission and pain physiology.
